ENTR'UP Entr'up develops and markets a software tool for managing...
SHOW YOU Show You develops virtual configuration software for real estate...
SWIKLY Online down payments and security...
NUKEYGARA 3D animation software for video game and animated...
COCOOM Internal media to federate employees around company's project and...
« Older Entries
The Food and Drug Administration (FDA) issues a favorable opinion on the preclinical development plan submitted by Theranexus and BBDF
Presentation of the results of the phase IB Clinical study of THN201 for Alzheimer’s disease at the clinical trials on Alzheimer’s disease conference (CTAD)
Theranexus et BBDF obtain European “orphan medicinal product” designation for BBDF-101 in Batten disease
Amolyt Pharma Doses First Subject in Phase 1 Clinical Trial of Parathyroid Hormone Analog, AZP-3601, for Hypoparathyroidism
Theranexus presents its latest scientific news